MedPath

Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin

Not Applicable
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Low fat diet
Dietary Supplement: High fat diet
Dietary Supplement: MCT diet
Registration Number
NCT00694512
Lead Sponsor
Oregon Health and Science University
Brief Summary

The purpose of this study is to learn more about how diet affects the hormone ghrelin. Ghrelin is made in the stomach and causes appetite to increase. Learning about ghrelin will help the investigators understand more about obesity.

Detailed Description

Control subjects will be provided 3 different diets for 2 weeks each. At the end of each diet period participants will be admitted to OHSU Clinical Translation Research Center (CTRC) for blood sampling every 30 minutes for 13.5 hours, to measure levels of hormones. Participants will also have a DXA scan to measure body composition.

PWS subjects will have one admission after eating a standardized diet prepared by caregivers for 2 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Age 18 or older.
  • Weight stable for at least 3 months.
  • At lifetime maximal body weight.
Exclusion Criteria
  • Actively losing weight by diet or exercise.
  • Smokers.
  • Alcohol consumption > 2 drinks per day.
  • Exercise > 30 minutes 3 times a week.
  • Prescription drug use (except birth control pills, vitamins, or minerals).
  • Type 2 diabetes.
  • Heart disease, cancer, malabsorptive states, or chronic infections that would affect body weight.
  • Weight > 300 lbs (exceeds the weight limit of the DEXA machine).
  • Hemoglobin < 12.0 g/dL for women, < 13.5 g/dL for men

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1Low fat dietlow fat diet for two weeks.
2High fat dietHigh fat diet for two weeks followed by blood sampling.
3MCT dietMedium Chain Triglyceride diet
Primary Outcome Measures
NameTimeMethod
The primary outcomes for aim 1 are the suppression of total and acylated ghrelin from peak fasting (highest value) level to nadir (lowest level) during the 4 hours after each meal, comparing the obese to the lean subjects.every 8 weeks
Secondary Outcome Measures
NameTimeMethod
Area-under-the-curve measurements during the 12 ½ hours of testing for ghrelin and other nutrient and gut-peptides, including glucose, insulin, PYY3-36, and active GLP-1.Every 8 weeks

Trial Locations

Locations (1)

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath